Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q3 2026Earnings call Nov 5, 2026 · most recent call
OSCR’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: Oscar Health, Inc.’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: OSCR daily prices (open, high, low, close) with a 50-day moving average; lines mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $2.39B | +67.1% | -$0.62 | — | -6.2% | -6.4% | $340M |
| FY2025 Q1 | $3.05B | +42.2% | $0.92 | +48.4% | 9.8% | 9.0% | $870M |
| FY2025 Q2 | $2.86B | +29.0% | -$0.89 | -545.0% | -8.0% | -8.0% | $500M |
| FY2025 Q3 | $2.99B | +23.2% | -$0.53 | n/m | -4.3% | -4.6% | -$974M |
| FY2025 Q4 | $2.81B | +17.3% | -$1.24 | n/m | -11.9% | -12.6% | $663M |
| FY2026 Q1 | $4.65B | +52.6% | $2.07 | +125.0% | 15.2% | 14.6% | $2.61B |
| FY2026 Q2 | $4.88B | +70.4% | $1.10 | n/m | 8.0% | 7.4% | $2.08B |
| FY2026 Q3Selected | $5.14B | +72.1% | $0.49 | n/m | 3.5% | 3.3% | -$1.21B |
FY2025 Q3: Prior-year quarter was a loss (-$0.22 EPS), so a percent change isn't meaningful.
FY2025 Q4: Prior-year quarter was a loss (-$0.62 EPS), so a percent change isn't meaningful.
FY2026 Q2: Prior-year quarter was a loss (-$0.89 EPS), so a percent change isn't meaningful.
FY2026 Q3: Prior-year quarter was a loss (-$0.53 EPS), so a percent change isn't meaningful.
Management-stated figures from OSCR’s newest call are part of Tellvest Pro.
No 8-K events recorded since this call day.
Full Pro access for 30 days when you create a free account. No credit card required.